Citation Impact
Citing Papers
Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial
2009
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
2011
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Targeting the tumor vasculature to enhance T cell activity
2015
Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer
2019 StandoutNobel
Multiple myeloma
2014
The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer
2007
EGFR Antagonists in Cancer Treatment
2008 Standout
Microsatellite instability in colorectal cancer—the stable evidence
2010
Treatment Decisions After Diagnosis of Metastatic Colorectal Cancer
2011
Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine
2016
Pharmacodynamic and pharmacogenomic study of the nanoparticle conjugate of camptothecin CRLX101 for the treatment of cancer
2014
From tumour heterogeneity to advances in precision treatment of colorectal cancer
2016
Microsatellite Instability in Colorectal Cancer
2010 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
2010
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
2009
Lung Cancer
2008 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
A Systems Approach for Tumor Pharmacokinetics
2011
Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited
2009
Tissue-specific tumorigenesis: context matters
2017
Hepatocellular carcinoma
2012 Standout
Hepatocellular carcinoma
2021 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer
2014
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
2014
Colorectal cancer
2013 Standout
An Update on the Current and Emerging Targeted Agents in Metastatic Colorectal Cancer
2011
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Colorectal cancer
2019 Standout
How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion Question
2009
The use of combinations of monoclonal antibodies in clinical oncology
2015
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Chemotherapy Maintenance
2016
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
2007
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial
2012
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Current understanding of the human microbiome
2018 Standout
Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma
1994
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2012 Standout
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
2011
Photodynamic therapy of cancer: An update
2011 Standout
A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity
2008
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Comprehensive analysis of kinase inhibitor selectivity
2011 Standout
Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
2009
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
2000 Standout
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Targeting the cancer kinome through polypharmacology
2010
Clinical Biomarkers in Oncology
2009
Immune thrombocytopenic purpura in adults
2007
Hepatocellular Carcinoma
2011 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
2010
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Engineered Proteins Pull Double Duty
2010
Enhancement of the Cytotoxicity and Selectivity of Doxorubicin to Hepatoma Cells by Synergistic Combination of Galactose-Decorated γ-Poly(glutamic acid) Nanoparticles and Low-Intensity Ultrasound
2014
Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
2009
Macromolecular therapeutics in cancer treatment: The EPR effect and beyond
2012
Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial
2010
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial
2008
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
2011
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience
2006
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Assessment of the In vivo Antitumor Effects of ENMD-2076, a Novel Multitargeted Kinase Inhibitor, against Primary and Cell Line–Derived Human Colorectal Cancer Xenograft Models
2010
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection.
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Multiple Myeloma
2011 Standout
Works of Harm Sinnige being referenced
Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature
2011
A phase I–II study of 14-days continuous infusion of 5-fluorouracil with weekly bolus leucovorin in metastatic colorectal carcinoma
1992
High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults
2004
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
2007
Melphalan + Prednisone Versus Melphalan + Prednisone + Thalidomide in Induction Therapy for Multiple Myeloma in Elderly Patients: Final Analysis of the Dutch Cooperative Group HOVON 49 Study
2008
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
2009
Phase III Study of the Value of Thalidomide Added to Melphalan Plus Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma: The HOVON 49 Study
2010